Dong-A Pharmaceutical Co Ltd Exports Zydena to Russia
Dong-A Pharmaceutical Co Ltd announced that its subsidiary, Dong-A Pharm-tech, entered into a five-year, US$50 Million contract with Otechestvennye Lekarstva OJSC to market Zydena, Dong-A's erectile dysfunction drug, in Russia.
Under the terms of the agreement, signed on October 15, 2007, Otechestvennye Lekarstva OJSC, one of the largest Russian pharmaceutical firms, will pay both upfront fees and running royalty on sales for the life of the contract.
Other news from the department business & finance

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
More news from our other portals
Last viewed contents

Alwin Höfert - Fabrikation von Spezialdichtungen - Ammersbek, Germany

Northwest Biotherapeutics, Inc. - Bothell, USA
Organizational changes at Bayer HealthCare - Streamlining administration, strengthening research and development
